The Role of CD36 in Cardiovascular Disease: A Critical Review
Hongyang Shu(Gangneung–Wonju National University), Dao Wen Wang(Tongji Hospital), Weijian Hang(Tongji Hospital), Yizhong Peng(Wuhan Union Hospital), Ning Zhou(Tongji Hospital), Jiali Nie(Tongji Hospital)
Cited by 0
Related Papers
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
|Science China Life Sciences|2020|176
Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases
|Science China Life Sciences|2020|159